In response to DNA damage, p53-induced protein with a death domain (PIDD) forms a complex called the PIDDosome, which either consists of PIDD, RIP-associated protein with a death domain and caspase-2, ...
In the United States, there are approximately 250,000 people diagnosed with primary immunodeficiency disease (PIDD), and thousands more go undetected. PIDD occurs in patients born with an immune ...
November 21, 2011 (Boston, Massachusetts) — A novel immunoglobulin (Ig)G replacement therapy that uses hyaluronidase to facilitate dosing with gammaglobulin has shown good efficacy in preventing ...
March 6, 2006 (Miami Beach) — A subcutaneous formulation of immunoglobulin replacement therapy ( Vivaglobin) produces results in primary immune deficiency diseases (PIDD) that are similar to those for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results